Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Breast cancer proteomics reveals a positive correlation between glyoxalase 1 expression and high tumor grade.
Fonseca-Sánchez MA, Rodríguez Cuevas S, Mendoza-Hernández G, Bautista-Piña V, Arechaga Ocampo E, Hidalgo Miranda A, Quintanar Jurado V, Marchat LA, Alvarez-Sánchez E, Pérez Plasencia C, López-Camarillo C. Fonseca-Sánchez MA, et al. Among authors: arechaga ocampo e. Int J Oncol. 2012 Aug;41(2):670-80. doi: 10.3892/ijo.2012.1478. Epub 2012 May 14. Int J Oncol. 2012. PMID: 22614840
MetastamiRs: non-coding MicroRNAs driving cancer invasion and metastasis.
Lopez-Camarillo C, Marchat LA, Arechaga-Ocampo E, Perez-Plasencia C, Moral-Hernandez OD, Castaneda-Ortiz EJ, Rodriguez-Cuevas S. Lopez-Camarillo C, et al. Among authors: arechaga ocampo e. Int J Mol Sci. 2012;13(2):1347-1379. doi: 10.3390/ijms13021347. Epub 2012 Jan 27. Int J Mol Sci. 2012. PMID: 22408395 Free PMC article. Review.
Proteomic profiling reveals that resveratrol inhibits HSP27 expression and sensitizes breast cancer cells to doxorubicin therapy.
Díaz-Chávez J, Fonseca-Sánchez MA, Arechaga-Ocampo E, Flores-Pérez A, Palacios-Rodríguez Y, Domínguez-Gómez G, Marchat LA, Fuentes-Mera L, Mendoza-Hernández G, Gariglio P, López-Camarillo C. Díaz-Chávez J, et al. Among authors: arechaga ocampo e. PLoS One. 2013 May 27;8(5):e64378. doi: 10.1371/journal.pone.0064378. Print 2013. PLoS One. 2013. PMID: 23724044 Free PMC article.
microRNA-18b is upregulated in breast cancer and modulates genes involved in cell migration.
Fonseca-Sanchéz MA, Pérez-Plasencia C, Fernández-Retana J, Arechaga-Ocampo E, Marchat LA, Rodríguez-Cuevas S, Bautista-Piña V, Arellano-Anaya ZE, Flores-Pérez A, Diaz-Chávez J, López-Camarillo C. Fonseca-Sanchéz MA, et al. Among authors: arechaga ocampo e. Oncol Rep. 2013 Nov;30(5):2399-410. doi: 10.3892/or.2013.2691. Epub 2013 Aug 22. Oncol Rep. 2013. PMID: 23970382
RAD50 targeting impairs DNA damage response and sensitizes human breast cancer cells to cisplatin therapy.
Flores-Pérez A, Rafaelli LE, Ramírez-Torres N, Aréchaga-Ocampo E, Frías S, Sánchez S, Marchat LA, Hidalgo-Miranda A, Quintanar-Jurado V, Rodríguez-Cuevas S, Bautista-Piña V, Carlos-Reyes A, López-Camarillo C. Flores-Pérez A, et al. Among authors: arechaga ocampo e. Cancer Biol Ther. 2014 Jun 1;15(6):777-88. doi: 10.4161/cbt.28551. Epub 2014 Mar 18. Cancer Biol Ther. 2014. PMID: 24642965 Free PMC article.
Differential proteomic analysis reveals that EGCG inhibits HDGF and activates apoptosis to increase the sensitivity of non-small cells lung cancer to chemotherapy.
Flores-Pérez A, Marchat LA, Sánchez LL, Romero-Zamora D, Arechaga-Ocampo E, Ramírez-Torres N, Chávez JD, Carlos-Reyes Á, Astudillo-de la Vega H, Ruiz-García E, González-Pérez A, López-Camarillo C. Flores-Pérez A, et al. Among authors: arechaga ocampo e. Proteomics Clin Appl. 2016 Feb;10(2):172-82. doi: 10.1002/prca.201500008. Epub 2015 Sep 14. Proteomics Clin Appl. 2016. PMID: 26175166
Tumor suppressor miR-29c regulates radioresistance in lung cancer cells.
Arechaga-Ocampo E, Lopez-Camarillo C, Villegas-Sepulveda N, Gonzalez-De la Rosa CH, Perez-Añorve IX, Roldan-Perez R, Flores-Perez A, Peña-Curiel O, Angeles-Zaragoza O, Rangel Corona R, Gonzalez-Barrios JA, Bonilla-Moreno R, Del Moral-Hernandez O, Herrera LA, Garcia-Carranca A. Arechaga-Ocampo E, et al. Tumour Biol. 2017 Mar;39(3):1010428317695010. doi: 10.1177/1010428317695010. Tumour Biol. 2017. PMID: 28345453 Free article.
New insights into radioresistance in breast cancer identify a dual function of miR-122 as a tumor suppressor and oncomiR.
Perez-Añorve IX, Gonzalez-De la Rosa CH, Soto-Reyes E, Beltran-Anaya FO, Del Moral-Hernandez O, Salgado-Albarran M, Angeles-Zaragoza O, Gonzalez-Barrios JA, Landero-Huerta DA, Chavez-Saldaña M, Garcia-Carranca A, Villegas-Sepulveda N, Arechaga-Ocampo E. Perez-Añorve IX, et al. Among authors: arechaga ocampo e. Mol Oncol. 2019 May;13(5):1249-1267. doi: 10.1002/1878-0261.12483. Epub 2019 Apr 18. Mol Oncol. 2019. PMID: 30938061 Free PMC article.
Randomized phase II trial of All-trans-retinoic acid with chemotherapy based on paclitaxel and cisplatin as first-line treatment in patients with advanced non-small-cell lung cancer.
Arrieta O, González-De la Rosa CH, Aréchaga-Ocampo E, Villanueva-Rodríguez G, Cerón-Lizárraga TL, Martínez-Barrera L, Vázquez-Manríquez ME, Ríos-Trejo MA, Alvarez-Avitia MA, Hernández-Pedro N, Rojas-Marín C, De la Garza J. Arrieta O, et al. Among authors: arechaga ocampo e. J Clin Oncol. 2010 Jul 20;28(21):3463-71. doi: 10.1200/JCO.2009.26.6452. Epub 2010 Jun 14. J Clin Oncol. 2010. PMID: 20547984 Clinical Trial.
35 results